Boy with Aplastic Anaemia will be saved by sister with donated stem cells
Scott Anderson, six, from Newcastle, suffers from Aplastic Anaemia, a rare illness which means his bone marrow is not making red blood cells, leaving him at risk of catching killer infections at any time. (Source: the Mail online | Health)
Source: the Mail online | Health - July 8, 2015 Category: Consumer Health News Source Type: news

In Aplastic Anemia, Only a Few Genes Matter (CME/CE)
(MedPage Today) -- Gene mutations identified to help select treatment for aplastic anemia patients (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - July 2, 2015 Category: Geriatrics Source Type: news

Longer Donor Telomeres May Confer Survival After Cell TransplantLonger Donor Telomeres May Confer Survival After Cell Transplant
Longer donor leukocyte telomeres may mean longer survival for aplastic anemia patients who undergo hematopoeitic cell transplantation (HCT), new findings show. Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 19, 2015 Category: Pathology Tags: Internal Medicine News Source Type: news

The Story Of Sharing America’s Marrow
(L-R) Taylor Shorten, Sam Kimura and Alex Kimura (photo courtesy of SAM) Two sisters and their best friend have set off on a courageous journey across the country to visit over 190 cities with a goal of registering 50,000 blood marrow donors.Alex and Sam Kimura of Louisville, Kentucky are the co-founders of Sharing America’s Marrow (SAM), a grassroots movement created years after Sam was diagnosed at age 17 with the rare bone marrow disease severe aplastic anemia. Although the cure is a blood marrow transplant, Sam, now 22, has been unable to find a match. With the support of Delete Blood Cancer DKMS, the two sisters and...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 18, 2015 Category: Consumer Health News Authors: mjweiss33 Tags: Boston's Best Family & Pets Health Alex Kimura Best Of blood cancer blood diseases bone marrow diseases bone marrow donors Delete Blood Cancer Donor Jam Louisville Kentucky Randy Yagi Sam Sam Kimura severe aplastic anemia S Source Type: news

Your NEJM Group Today: Marginal Healthcare, Longer Telomeres for Aplastic Anemia, Virginia Hospitalist Opportunities (FREE)
By The Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 11, 2015 Category: Primary Care Source Type: news

GSK seeks European approval for eltrombopag to treat severe aplastic anaemia
British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 13, 2014 Category: Pharmaceuticals Source Type: news

Gene mutation discovered in blood disorder aplastic anemia
A gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells, has been discovered by an international team of scientists. The gene regulates telomeres on the ends of chromosomes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 23, 2014 Category: Science Source Type: news

Gene mutation discovered in blood disorder
(Children's Hospital of Philadelphia) An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which three generations had blood disorders, the researchers discovered a defect in a gene that regulates telomeres, chromosomal structures with crucial roles in normal cell function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 23, 2014 Category: Global & Universal Source Type: news

Back in the game after stem cell transplant
By Irene Sege Some 100 days after receiving a stem cell transplant to cure his severe aplastic anemia, Behaylu Barry still couldn’t invite friends into his home. He wouldn’t be returning to school until January because his immune system needs the time to get strong enough to fight the pathogens present in indoor spaces. But 13-year-old Behaylu was doing so well that his doctor cleared him to play soccer – outdoors, of course — for the first time since February, when he was diagnosed with the life-threatening blood disorder shortly before he was to join the competitive soccer team that had just selected him. So ...
Source: Thrive, Children's Hospital Boston - September 8, 2014 Category: Pediatrics Authors: Guest Blogger Tags: All posts Aplastic anemia Dana-Farber/Boston Children's Transplant center Stem cell Stem Cell Transplant Program Source Type: news

FDA clears GSK’s Promacta sNDA to treat SAA patients
The US Food and Drug Administration (FDA) has given its clearance to supplemental new drug application (sNDA) for GlaxoSmithKline's (GSK) Promacta (eltrombopag) to treat patients with severe aplastic anaemia (SAA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 27, 2014 Category: Pharmaceuticals Source Type: news

FDA OKs Eltrombopag (Promacta) for Severe Aplastic AnemiaFDA OKs Eltrombopag (Promacta) for Severe Aplastic Anemia
Eltrombopag is indicated for patients with severe aplastic anemia who fail to respond adequately to immunosuppressive therapy. FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 26, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Adopted from Ethiopia, his African siblings travel to Boston to save his life
By Irene Sege One morning in 2006, Aidan Barry showed his wife, Midori Kobayashi, a newspaper story on the plight of the lost boys of Sudan and children affected by the diamond war in Sierra Leone. Little did the Stratham, N.H., couple know that this moment at their breakfast table would lead them to adopt a 6-year-old boy from Ethiopia whose desperately poor parents could not support all their children. Neither could they predict that, seven years later, their adopted son would develop a life-threatening blood disorder connecting his adopted family and birth family for a stem cell transplant to offer him the best chance o...
Source: Thrive, Children's Hospital Boston - May 22, 2014 Category: Pediatrics Authors: Guest Blogger Tags: All posts Aplastic anemia Dana-Farber/Boston Children's Cancer and Blood Disorders Center our patients' stories Stem cell Stem Cell Transplant Program Source Type: news

GSK announces submission to U.S. regulatory authorities for Promacta™ (eltrombopag) for severe aplastic anaemia
GlaxoSmithKline plc (LSE:GSK) announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Promacta™ (eltrombopag). (Source: GSK news)
Source: GSK news - February 28, 2014 Category: Pharmaceuticals Source Type: news

FDA grants breakthrough therapy status to GSK's anaemia drug eltrombopag
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for GlaxoSmithKline's (GSK) Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anaemia (SAA) who have had insufficien… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 6, 2014 Category: Pharmaceuticals Source Type: news

GSK gains FDA Breakthrough Therapy designation for Promacta®/Revolade® (eltrombopag) for severe aplastic anaemia
GlaxoSmithKline plc (LSE:GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Promacta®/Revolade® (eltrombopag). (Source: GSK news)
Source: GSK news - February 3, 2014 Category: Pharmaceuticals Source Type: news